Regulation of Renin Expression by Β1-Integrin in As4.1 Juxtaglomerular Line Cells.
Nobumichi SaitoMasao ToyodaMasumi KondoMakiko AbeNoriyuki SanechikaMoritsugu KimuraKaichiro SawadaMasafumi FukagawaPublished in: Biomedicines (2023)
(1) Background: Renal dysfunction and hypertension are mutually aggravating factors; however, the details of their interaction remain unclear. In a study using renal tissue from diabetic rats, we found that β1-integrin, a cell-substrate adhesion molecule, is specifically phosphorylated in juxtaglomerular cells that secrete renin, a blood pressure regulator. (2) Methods: A mouse juxtaglomerular cell line (As4.1 cells) was used for the following experiments: drug-induced promotion of β1-integrin phosphorylation/dephosphorylation; knockdown of β1-integrin and the cell adhesion molecule connexin-40 (a candidate for the main body of baroreceptor); and pressurization to atmospheric pressure + 100 mmHg. culture in hypotonic liquid medium. The expression of renin under these conditions was measured by qRT-PCR. (3) Results: Phosphorylation of β1-integrin suppressed the expression of renin, while dephosphorylation conversely promoted it. β1-integrin and connexin-40 knockdown both promoted the expression of renin. Pneumatic pressurization and hypotonic medium culture both decreased the expression of renin, which was restored by the knockdown of β1-integrin. (4) Conclusions: β1-integrin plays an inhibitory role in the regulation of the expression of renin, which may be controlled by phosphorylation and dephosphorylation. It is hypothesized that β1-integrin and other adhesion factors regulate the expression of renin by altering the sensitivity of baroreceptors on the plasma membrane.
Keyphrases
- cell adhesion
- poor prognosis
- blood pressure
- induced apoptosis
- oxidative stress
- angiotensin converting enzyme
- binding protein
- cell cycle arrest
- long non coding rna
- diabetic rats
- type diabetes
- escherichia coli
- cell death
- staphylococcus aureus
- adipose tissue
- weight loss
- bone marrow
- cystic fibrosis
- insulin resistance
- mesenchymal stem cells
- air pollution
- hypertensive patients
- cell therapy
- real time pcr